Drug intelligence / Profile preview

Changjitai

Development stage: Preclinical
Lead developer: JSP Pharmaceutical Manufacturing
Modality: Small Molecules
Administration: Oral

Overview

Changjitai is a traditional Chinese herbal compound formulation studied for its potential to alleviate cancer-related fatigue, particularly in postoperative colorectal cancer patients. It is sometimes used in combination with other therapies such as ear acupuncture. The precise composition of the herbal ingredients and the detailed mechanism of action are not specified in available sources, but it is categorized as a multi-ingredient traditional Chinese medicine (TCM) product. Its effects are likely mediated through multiple pathways associated with TCM principles, possibly including immunomodulation and support for energy metabolism[2].

Brand names: Changjitai
Other names: ChangjitaiChinese Compound Changjitai

Beyond the preview

Go deeper on Changjitai.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changjitai.

Explore the full profile